APTO APTOSE BIOSCIENCES INC revenue, earnings and financials

For the quarter ended March 31, 2026, APTOSE BIOSCIENCES INC reported revenue of $0, net income of −$7.63M and diluted EPS of −$2.99; over the last four quarters revenue was $0 and net income −$27.6M; for the fiscal year ended December 2025 revenue was $0.

APTO annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $0, gross profit n/a, operating income n/a, net income −$25.5M (margin n/a), EPS −$10.41
• Fiscal year ended Dec 2024: revenue $0, gross profit n/a, operating income n/a, net income −$25.4M (margin n/a), EPS −$36.38
• Fiscal year ended Dec 2023: revenue $0, gross profit n/a, operating income n/a, net income −$51.2M (margin n/a), EPS −$227.43
• Fiscal year ended Dec 2022: revenue $0, gross profit n/a, operating income n/a, net income −$41.8M (margin n/a), EPS −$6.80
• Fiscal year ended Dec 2021: revenue $0, gross profit n/a, operating income n/a, net income −$65.4M (margin n/a), EPS −$0.73

APTO quarterly revenue and earnings

• Quarter ended Mar 31, 2026: revenue $0, net income −$7.63M, EPS −$2.99
• Quarter ended Dec 31, 2025 (from the annual report): revenue $0, net income −$7.76M, EPS −$3.03
• Quarter ended Sep 30, 2025: revenue $0, net income −$5.12M, EPS −$2.01
• Quarter ended Jun 30, 2025: revenue $0, net income −$7.04M, EPS −$2.76
• Quarter ended Mar 31, 2025: revenue $0, net income −$5.54M, EPS −$2.61
• Quarter ended Dec 31, 2024 (from the annual report): revenue $0, net income −$1.59M, EPS $9.96
• Quarter ended Sep 30, 2024: revenue $0, net income −$6.95M, EPS −$11.33
• Quarter ended Jun 30, 2024: revenue $0, net income −$7.25M, EPS −$12.99
• Quarter ended Mar 31, 2024: revenue $0, net income −$9.64M, EPS −$22.02
• Quarter ended Dec 31, 2023: revenue $0, net income −$12.0M, EPS −$1.57
• Quarter ended Sep 30, 2023: revenue $0, net income −$11.4M, EPS −$1.76
• Quarter ended Jun 30, 2023: revenue $0, net income −$14.1M, EPS −$2.27
• Quarter ended Mar 31, 2023: revenue $0, net income −$13.7M, EPS −$2.22
• Quarter ended Dec 31, 2022: revenue $0, net income −$10.0M, EPS −$1.67
• Quarter ended Sep 30, 2022: revenue $0, net income −$9.78M, EPS −$1.66
• Quarter ended Jun 30, 2022: revenue $0, net income −$10.6M, EPS −$1.66
• Quarter ended Mar 31, 2022: revenue $0, net income −$11.5M, EPS −$1.81
• Quarter ended Dec 31, 2021: revenue $0, net income −$24.3M, EPS −$0.27
• Quarter ended Sep 30, 2021: revenue $0, net income −$11.3M, EPS −$0.13
• Quarter ended Jun 30, 2021: revenue $0, net income −$13.5M, EPS −$0.15

APTO cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$22.0M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$36.0M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$44.6M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$32.3M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$43.3M, share buybacks n/a

APTO balance sheet

• Mar 31, 2026: cash n/a, total assets $10.7M, total liabilities $45.4M, shareholders' equity −$34.7M
• Dec 31, 2025: cash $935K, total assets $10.0M, total liabilities $37.2M, shareholders' equity −$27.2M
• Sep 30, 2025: cash $613K, total assets $6.34M, total liabilities $25.8M, shareholders' equity −$19.5M
• Jun 30, 2025: cash $553K, total assets $5.59M, total liabilities $20.0M, shareholders' equity −$14.4M
• Mar 31, 2025: cash $4.74M, total assets $7.47M, total liabilities $14.9M, shareholders' equity −$7.39M
• Dec 31, 2024: cash $6.15M, total assets $10.1M, total liabilities $14.7M, shareholders' equity −$4.54M
• Sep 30, 2024: cash $7.96M, total assets $10.9M, total liabilities $20.1M, shareholders' equity −$9.13M
• Jun 30, 2024: cash $8.33M, total assets $10.9M, total liabilities $13.1M, shareholders' equity −$2.18M

What is APTO's revenue?

APTOSE BIOSCIENCES INC reported $0 of revenue over its last four quarters, through March 31, 2026.

Is APTO profitable?

No. APTOSE BIOSCIENCES INC lost $27.6M over the last four quarters.

What is APTO's EPS?

Diluted earnings per share over the last four quarters were −$10.79; −$2.99 in the latest quarter.

APTO ownership and insider trades · All stocks